コギソ トモミ
Kogiso Tomomi
小木曽 智美 所属 医学部 医学科(東京女子医科大学病院) 職種 講師 |
|
論文種別 | 総説 |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma. |
掲載誌名 | 正式名:Cancers 略 称:Cancers (Basel) ISSNコード:20726694/20726694 |
掲載区分 | 国外 |
巻・号・頁 | 13(3),pp.516 |
著者・共著者 | KOGISO Tomomi, TOKUSHIGE Katsutoshi |
担当区分 | 筆頭著者,責任著者 |
発行年月 | 2021/01 |
概要 | Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and can develop into hepatocellular carcinoma (HCC). The incidence of NAFLD-related HCC, which is accompanied by life-threatening complications, is increasing. Advanced fibrosis and lifestyle-related and metabolic comorbidities, especially obesity and diabetes mellitus, are associated with HCC development. However, HCC is also observed in the non-cirrhotic liver. Often, diagnosis is delayed until the tumor is relatively large and the disease is advanced; an effective screening or surveillance method is urgently required. Recently, the NAFLD/nonalcoholic steatohepatitis (NASH) guidelines of Japan were revised to incorporate new strategies and evidence for the management and surveillance of NAFLD/NASH. Fibrosis must be tested for noninvasively, and the risk of carcinogenesis must be stratified. The treatment of lifestyle-related diseases is expected to reduce the incidence of NAFLD and prevent liver carcinogenesis. |
DOI | 10.3390/cancers13030516 |
PMID | 33572797 |